Dr. Reddy’s Generic HIV Prevention Shot Wins Tentative FDA Approval at $40 a Year in 120 Countries

The FDA has tentatively approved Dr. Reddy’s generic injectable lenacapavir for HIV prevention, potentially bringing a twice-yearly shot costing about $40 annually to 120 countries.